Our drug, RLC/929, has the ability to activate PKC which in turn initiates a cascade of cellular functions; by helping a variety of cell types to return to its normal state (differentiation); regulate the body’s immune system (cytokine regulation); and regulate the body’s natural water channels (aquaporin regulation). RLC/939 offers a targeted approach to promoting recovery and resilience.
RLC/929 begins working at the cellular level by binding to the C1 region of Protein Kinase C (PKC), PKC being a key enzyme that helps control how cells communicate, grow, and react to their environment. PKC acts like a "molecular switchboard" inside human cells, helping translate signals at the cell membrane into instructions that can influence repair through differentiation, promote cell survival, and return cells to normal function.